Target intelligence / Profile preview

Melanosomal transfer machinery

Molecular classification
Protein complex, GTPase, Motor protein, Receptor, Transport machinery
01

Overview

The melanosomal transfer machinery is a complex biological system responsible for the movement of melanin-containing organelles, called melanosomes, from melanocytes to neighboring keratinocytes in the epidermis. This process is essential for skin pigmentation and photoprotection against ultraviolet radiation (PMID: 12185071). The machinery involves a tripartite protein complex consisting of Rab27a, Melanophilin (MLPH), and Myosin Va (MYO5A), which facilitates the transport of melanosomes along actin filaments to the melanocyte dendrites (PMID: 11748271). Once at the periphery, the transfer to keratinocytes is mediated by mechanisms such as membrane fusion, exocytosis, or phagocytosis, the latter of which is significantly regulated by the Protease-activated receptor 2 (PAR2) on keratinocytes (PMID: 10844477). Dysregulation of this machinery is a primary driver of hyperpigmentary disorders like melasma and solar lentigo, while genetic mutations in its core components lead to Griscelli syndrome. Pharmacological intervention often targets this machinery using agents like niacinamide, which inhibits the transfer process, or PAR2 inhibitors to reduce visible pigmentation without necessarily affecting melanin synthesis itself (PMID: 12100180).

Other names
Melanosome transport systemMelanosome translocation complexMelanocyte-keratinocyte transfer systemRab27a-MLPH-MYO5A complex
02

Mechanism of action

Inhibition of melanosome transfer from melanocytes to keratinocytes by blocking PAR2-mediated phagocytosis or disrupting the Rab27a-Melanophilin-Myosin Va transport complex.

03

Biological functions

PigmentationIntracellular transportExocytosisPhagocytosisUV protection
04

Disease associations

HyperpigmentationMelasmaGriscelli syndromePost-inflammatory hyperpigmentationSolar lentigo
05

Safety considerations

Post-inflammatory hypopigmentationSkin irritationPotential for uneven skin toneCompromised UV protection
06

Interacting drugs

Niacinamide

4 more in the full profile.

07

Biomarkers

Melanin indexPAR2 expression levelsRab27a expressionMelanosome distribution

Beyond the preview

Go deeper on Melanosomal transfer machinery.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Melanosomal transfer machinery.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call